Page last updated: 2024-08-21

quinazolines and embelin

quinazolines has been researched along with embelin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aird, KM; Devi, GR; Ghanayem, RB; Lyerly, HK; Peplinski, S	1

Other Studies

1 other study(ies) available for quinazolines and embelin

Article	Year
X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor. Molecular cancer therapeutics, 2010, Volume: 9, Issue:5 Topics: Antineoplastic Agents; Apoptosis; Benzoquinones; Breast Neoplasms; Carcinoma; Cells, Cultured; Down-Regulation; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; ErbB Receptors; Feasibility Studies; Female; Gene Expression Regulation, Neoplastic; Humans; Mastitis; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Sulfones; X-Linked Inhibitor of Apoptosis Protein	2010

Article

Year

X-linked inhibitor of apoptosis protein inhibits apoptosis in inflammatory breast cancer cells with acquired resistance to an ErbB1/2 tyrosine kinase inhibitor.

Molecular cancer therapeutics, 2010, Volume: 9, Issue:5

Topics: Antineoplastic Agents; Apoptosis; Benzoquinones; Breast Neoplasms; Carcinoma; Cells, Cultured; Down-Regulation; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; ErbB Receptors; Feasibility Studies; Female; Gene Expression Regulation, Neoplastic; Humans; Mastitis; Protein Kinase Inhibitors; Quinazolines; Receptor, ErbB-2; Sulfones; X-Linked Inhibitor of Apoptosis Protein

2010